Gilead Sciences, US3755581036

Gilead Sciences stock slips 1.30 percent at the close

Published on 09/23/2026 at 23:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Gilead Sciences stock traded at USD 150.68 on the Nasdaq, down 1.30 percent at 1:48 p.m. ET. The reported 52-week range was USD 108.46 to USD 157.29.

Photorealistischer Biotech-Campus von Gilead Sciences mit Glaslabor und Wissenschaftlern
Gilead Sciences Forschungscampus mit ISIN US3755581036 modernes Biopharma-Labor Kalifornien Glasfassade Wissenschaftler arbeiten, Illustration mit AI erstellt.

Gilead Sciences stock traded at USD 150.68 on the Nasdaq on September 23, 2026, down 1.30 percent at 1:48 p.m. ET. The session value was USD 6.61 below the reported 52-week high of USD 157.29.

September 23, 2026 session figures

Gilead Sciences, Inc. (ISIN US3755581036, Nasdaq: GILD) was quoted at USD 150.68 with 1,659,261 shares traded at 1:48 p.m. ET. The reported 52-week range ran from USD 108.46 to USD 157.29, placing the quote USD 42.22 above the low and USD 6.61 below the high.

The latest dated closing report placed the prior Nasdaq close at USD 149.56 on September 22, 2026. That report also stated that quarterly revenue had risen 10.6 percent to USD 7.80 billion, but the figure concerned the earlier reported quarter rather than the September 23 session.

Next earnings date

Gilead is scheduled to report its next earnings on October 22, 2026, according to AD HOC NEWS. The U.S. extended session continues until 8:00 p.m. ET on September 23, 2026.

Disclaimer...

en | US3755581036 | GILEAD SCIENCES | boerse | 70170912 | bgmi